Pictet Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Buy |
1,998,634
+244,354
| +14% | +$2.78M | 0.02% | 481 |
|
|
2025
Q1 | $20.8M | Sell |
1,754,280
-14,637
| -0.8% | -$174K | 0.02% | 483 |
|
|
2024
Q4 | $33.3M | Sell |
1,768,917
-19,613
| -1% | -$370K | 0.04% | 378 |
|
|
2024
Q3 | $40.2M | Buy |
1,788,530
+615,012
| +52% | +$13.8M | 0.04% | 336 |
|
|
2024
Q2 | $24.5M | Buy |
1,173,518
+446,577
| +61% | +$9.32M | 0.03% | 418 |
|
|
2024
Q1 | $10.7M | Sell |
726,941
-46,647
| -6% | -$686K | 0.01% | 636 |
|
|
2023
Q4 | $7.98M | Sell |
773,588
-124,221
| -14% | -$1.28M | 0.01% | 695 |
|
|
2023
Q3 | $7.06M | Buy |
+897,809
| New | +$7.06M | 0.01% | 694 |
|